Divya Patel, MD
Physical Medicine and Rehabilitation · Rocky Mount, NCNPI 1609989870
Payments from drug & device makers
Across 74 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zyla Life Sciences, Inc.$469
- Supernus Pharmaceuticals, Inc.$242
- Abbott$152
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$130
- Takeda Pharmaceuticals U.S.A., Inc.$99
- Medtronic$89
- plus $374 from 12 others
What the payments were for
- Food & beverage$1,15074%
- Education$40626%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zyla Life Sciences, Inc. | 12 | $469 |
| Supernus Pharmaceuticals, Inc. | 15 | $242 |
| Abbott | 9 | $152 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Medtronic | 1 | $89 |
| Daiichi Sankyo Inc. | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| AstraZeneca | 4 | $51 |
| Sonex Health, Inc. | 1 | $38 |
| Nevro Corp. | 2 | $38 |
| Pfizer | 2 | $28 |
| Sentynl Therapeutics, Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Shionogi Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORVOLEX$406
How this compares
$1,556 in reported general payments places this provider in the 70th percentile of 269 physical medicine and rehabilitation providers in North Carolina.
See all physical medicine and rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 94 | $70,859 |
| LinzessLinaclotide | 112 | $63,581 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,418 | $35,832 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $29,977 |
| MovantikNaloxegol Oxalate | 59 | $27,800 |
| Lidocaine | 128 | $25,871 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 977 | $18,678 |
| Xtampza ErOxycodone Myristate | 29 | $8,282 |
| Tizanidine Hcl | 501 | $7,878 |
| Fentanyl | 72 | $7,184 |
| Duloxetine Hcl | 528 | $6,748 |
| Oxycodone Hcl | 454 | $6,440 |
| Gabapentin | 440 | $5,252 |
| Buprenorphine | 12 | $4,946 |
| Cyclobenzaprine Hcl | 433 | $4,783 |
Paid to pharmacies, not to this prescriber.
Other physical medicine and rehabilitation in Rocky Mount
- William BockenekCharlotte$446K
- Andrew SumichCharlotte$181K
- Jeremy HoffWilmington$152K
- William BeckworthHendersonville$104K
- Patrick O BrienRaleigh$86K
- Michael OrtizCharlotte$62K
- Elizabeth BagsbyGreenville$33K
- Krishna BhatSanford$30K
- Jasbir DhaliwalSanford$23K
- Jimmy MaliDurham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.